TBCC Inhibitors

Chemical inhibitors of TBCC can exert their inhibitory effects through various interactions with tubulin, the protein that TBCC helps fold and incorporate into microtubules. Paclitaxel, for example, stabilizes microtubules and inhibits their disassembly, which undermines the role of TBCC in microtubule dynamics. Similarly, Vincristine and Vinblastine bind directly to tubulin, inhibiting its polymerization and thus impeding the TBCC's association with tubulin. This disruption to the normal polymerization process directly inhibits the functional activity of TBCC. Colchicine and Podophyllotoxin also bind to tubulin, with an inhibition of polymerization that subsequently restricts the operational capacity of TBCC in microtubule formation. Nocodazole and Griseofulvin disrupt microtubule networks by inhibiting tubulin polymerization as well, which indirectly hampers TBCC's function in microtubule assembly and maintenance.

Continuing with the theme of tubulin interaction, Eribulin binds to the growth ends of microtubules, sequestering tubulin into non-functional aggregates that TBCC is then unable to utilize effectively. Vinflunine destabilizes microtubules and their assembly by binding to tubulin, which can suppress TBCC due to its role in stabilizing microtubule formation. Peloruside A locks tubulin in a polymerized state, thereby preventing TBCC from participating in its typical role of aiding microtubule formation and stability. Combretastatin A4 targets tubulin and its assembly into microtubules, directly inhibiting the functional activity of TBCC as it relies on tubulin polymerization to exert its effects. Lastly, 2-Methoxyestradiol also binds to tubulin and obstructs its polymerization, which results in an indirect inhibition of TBCC's function within the cellular microtubule network. Each of these chemicals interacts with the microtubule assembly process in such a way that the function of TBCC, as a protein that is critical for proper microtubule formation and stability, is inhibited.